Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

25.07.2022

1 Acta Neurol Scand
2 BMC Neurol
8 Diabet Med
2 Intern Med
2 J Autoimmun
2 J Clin Endocrinol Metab
1 J Immunol
4 J Neuroimmunol
5 Lancet Neurol
3 Mult Scler
1 N Engl J Med
1 Nat Rev Neurol
2 Neurologia (Engl Ed)
2 PLoS One
1 Proc Natl Acad Sci U S A



    Acta Neurol Scand

  1. MAGALHAES JE, Sampaio-Rocha-Filho PA
    Reply: Neurological disease in pregnant females with COVID-19 may not only be attributable to SARS-CoV-2.
    Acta Neurol Scand. 2022;146:201-202.
    >> Share


    BMC Neurol

  2. ANDELOVA M, Vodehnalova K, Krasensky J, Hardubejova E, et al
    Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.
    BMC Neurol. 2022;22:270.
    >> Share

  3. DANG J, Lei S, Chen J
    Autoimmune glial fibrillary acidic protein astrocytopathy presented as isolated area postrema symdrome: a case report.
    BMC Neurol. 2022;22:271.
    >> Share


    Diabet Med

  4. JOENSEN LE, Steenberg JL, Madsen KP, Willaing I, et al
    What people with diabetes in Denmark worry about during the COVID-19 pandemic: a longitudinal study of the first three months of the COVID-19 pandemic.
    Diabet Med. 2021 Jul 30:e14665. doi: 10.1111/dme.14665.
    >> Share

  5. DYBJER E, Dahl Aslan AK, Engstrom G, Nilsson ED, et al
    Type 1 diabetes, cognitive ability and incidence of cardiovascular disease and death over 60 years of follow-up time in men.
    Diabet Med. 2022 Feb 7:e14806. doi: 10.1111/dme.14806.
    >> Share

  6. MACKENZIE SC, Cumming KM, Mehar S, Wilson L, et al
    Education at Scale: Improvements in Type 1 Diabetes Self-Management Following a Massive Open Online Course (MOOC).
    Diabet Med. 2022 Apr 15:e14842. doi: 10.1111/dme.14842.
    >> Share

  7. ELBALSHY M, Haszard J, Smith H, Kuroko S, et al
    Effect of Divergent Continuous Glucose Monitoring Technologies on Glycaemic Control in Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Diabet Med. 2022 Apr 20:e14854. doi: 10.1111/dme.14854.
    >> Share

  8. JOENSEN LE, Schultz AA, Madsen KP, Persson F, et al
    Flexible inclusion of dialogue about psychosocial aspects of life with type 1 diabetes in routine consultations - a study of a questionnaire-based dialogue tool to promote person-centered support.
    Diabet Med. 2022 May 13:e14881. doi: 10.1111/dme.14881.
    >> Share

  9. LEE VTY, Poynten A, Depczynski B
    Continuous Glucose Monitoring to Assess Glucose Variability in Type 3c Diabetes.
    Diabet Med. 2022 May 15:e14882. doi: 10.1111/dme.14882.
    >> Share

  10. FANG X, Jin L, Tang M, Lu W, et al
    Common single-nucleotide polymorphisms Combined with a Genetic Risk Score Provide New Insights Regarding the Etiology of Gestational Diabetes Mellitus.
    Diabet Med. 2022 May 19:e14885. doi: 10.1111/dme.14885.
    >> Share

  11. ABRAIMOVA A, Besancon S, Portocarrero J, Ramaiya K, et al
    Management of type 1 diabetes in low- and middle-income countries: comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.
    Diabet Med. 2022 May 27:e14891. doi: 10.1111/dme.14891.
    >> Share


    Intern Med

  12. ITO T, Fukui S, Suda M, Okada M, et al
    Large-vessel Vasculitis of Extremities without Aortic Involvement.
    Intern Med. 2022;61:2243.
    >> Share

  13. MIYAGAWA K, Kumamoto K, Shinohara N, Watanabe T, et al
    Autoimmune Pancreatitis with Gastric Cancer: Some IgG4-related Diseases May Be Paraneoplastic Syndrome.
    Intern Med. 2022;61:2155-2160.
    >> Share


    J Autoimmun

  14. FERRI C, Gragnani L, Raimondo V, Visentini M, et al
    Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
    J Autoimmun. 2022;131:102866.
    >> Share

  15. LIU Y, Yu X, Zhang W, Zhang X, et al
    Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    J Autoimmun. 2022 Jul 16:102863. doi: 10.1016/j.jaut.2022.102863.
    >> Share


    J Clin Endocrinol Metab

  16. NIMRI R, Marianna R, Yackobovitch-Gavan M, Brener A, et al
    Symptoms and Glycemic Control in Young People with Type 1 Diabetes following SARS-CoV-2 Infection: an Observational Study.
    J Clin Endocrinol Metab. 2022 May 7. pii: 6582248. doi: 10.1210.
    >> Share

  17. BAIDAL DA, Warnock M, Xu P, Geyer S, et al
    Oral Glucose Tolerance Test Measures of First-Phase Insulin Response and their Predictive Ability for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2022 May 7. pii: 6582280. doi: 10.1210.
    >> Share


    J Immunol

  18. DWYER JR, Racine JJ, Chapman HD, Quinlan A, et al
    Nfkbid Overexpression in Nonobese Diabetic Mice Elicits Complete Type 1 Diabetes Resistance in Part Associated with Enhanced Thymic Deletion of Pathogenic CD8 T Cells and Increased Numbers and Activity of Regulatory T Cells.
    J Immunol. 2022 Jun 27. pii: jimmunol.2100558. doi: 10.4049/jimmunol.2100558.
    >> Share


    J Neuroimmunol

  19. VAN DER WEELE L, Pollastro S, van Schaik BDC, van Kampen AHC, et al
    Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif) using B cell receptor repertoire analysis.
    J Neuroimmunol. 2022;370:577932.
    >> Share

  20. KASHEKE GDS, Holman SP, Robertson GS
    Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2022;370:577926.
    >> Share

  21. WEIHUA Z, Haitao R, Jie D, Changhong R, et al
    Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases.
    J Neuroimmunol. 2022;370:577918.
    >> Share

  22. FONAGER SV, Winther G, Wittenborn TR, Jensen L, et al
    Increased maternofoetal transfer of antibodies in a murine model of systemic lupus erythematosus, but no immune activation and neuroimmune sequelae in offspring.
    J Neuroimmunol. 2022;370:577927.
    >> Share


    Lancet Neurol

  23. SVENNINGSSON A, Frisell T, Burman J, Salzer J, et al
    Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial.
    Lancet Neurol. 2022;21:693-703.
    >> Share

  24. HUIJBERS MG, Punga A, Verschuuren JJ
    Antibiotic neuromuscular junction myasthenic mimetics - Authors' reply.
    Lancet Neurol. 2022;21:681.
    >> Share

  25. UZOIGWE CE, Campbell-Jones F
    Antibiotic neuromuscular junction myasthenic mimetics.
    Lancet Neurol. 2022;21:681.
    >> Share

  26. HVID LG, Langeskov-Christensen M, Stenager E, Dalgas U, et al
    Exercise training and neuroprotection in multiple sclerosis.
    Lancet Neurol. 2022;21:681-682.
    >> Share

  27. NAISMITH RT, Cross AH
    Further support for rituximab in relapsing multiple sclerosis.
    Lancet Neurol. 2022;21:672-673.
    >> Share


    Mult Scler

  28. KLISTORNER S, Barnett MH, Klistorner A
    Mechanisms of central brain atrophy in multiple sclerosis.
    Mult Scler. 2022 Jul 21:13524585221111684. doi: 10.1177/13524585221111684.
    >> Share

  29. JOHNSSON M, Farman HH, Blennow K, Zetterberg H, et al
    No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab.
    Mult Scler. 2022 Jul 20:13524585221108080. doi: 10.1177/13524585221108080.
    >> Share

  30. KRIEGER SC, Antoine A, Sumowski JF
    EDSS 0 is not normal: Multiple sclerosis disease burden below the clinical threshold.
    Mult Scler. 2022 Jul 13:13524585221108297. doi: 10.1177/13524585221108297.
    >> Share


    N Engl J Med

  31. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    >> Share


    Nat Rev Neurol

  32. MARRIE RA, Allegretta M, Barcellos LF, Bebo B, et al
    From the prodromal stage of multiple sclerosis to disease prevention.
    Nat Rev Neurol. 2022 Jul 15. pii: 10.1038/s41582-022-00686.
    >> Share


    Neurologia (Engl Ed)

  33. VAZQUEZ-MARRUFO M, Sarrias-Arrabal E, Garcia-Torres M, Martin-Clemente R, et al
    A systematic review of the application of machine-learning algorithms in multiple sclerosis.
    Neurologia (Engl Ed). 2022 Jul 14. pii: S2173-5808(22)00075.
    >> Share

  34. AGUIRRE F, Fernandez RN, Arrejoria RM, Manin A, et al
    Peak expiratory flow and the single-breath counting test as markers of respiratory function in patients with myasthenia gravis.
    Neurologia (Engl Ed). 2022 Jul 13. pii: S2173-5808(22)00076.
    >> Share


    PLoS One

  35. ZANOTTO T, Rice LA, Sosnoff JJ
    Frailty among people with multiple sclerosis who are wheelchair users.
    PLoS One. 2022;17:e0271688.
    >> Share

  36. SHAH R, Mohammed YN, Koehler TJ, Kaur J, et al
    Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study.
    PLoS One. 2022;17:e0269466.
    >> Share


    Proc Natl Acad Sci U S A

  37. FRESQUET M, Lockhart-Cairns MP, Rhoden SJ, Jowitt TA, et al
    Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch.
    Proc Natl Acad Sci U S A. 2022;119:e2202209119.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016